Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer

Eleftherios P. Mamounas, Charles E. Geyer, Sandra M. Swain

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences